• Kapate, N.
• Mitragotri, Samir
• Bibbey, G.
• Dunne, M.
• Curreri, A. M.
• Kim, J.

Abstract

<jats:title>Abstract</jats:title><jats:p>Messenger RNA has long been touted as a next‐generation therapeutic modality for infectious disease, cancer, and genetic disorders. Lipid nanoparticles provide an elegant delivery strategy for mRNA cargo to help realize this potential for vaccination. However, systemic exposure seen with traditional LNP formulations can have significant implications on efficacy and safety. Efforts to mitigate this have largely been focused on laborious lipid or LNP redesign. Here, we report the use of a deep eutectic‐lipid nanocomposite delivery system for the tuning of mRNA expression for intramuscular injections in vivo. One deep eutectic, cholinium malonate, allows for the linear control of percent expression at the muscular injection site based solely on its concentration in the formulation. The same DES can increase local muscle expression by 68% and significantly decrease off‐target liver expression by 72%. Physico‐chemical studies suggest that the DES incorporates into or onto the pre‐formed LNPs thus impacting endosomal escape and in situ interactions. These nanocomposites provide new possibilities for previously approved LNP formulations and without the need for lipid redesign to induce localized expression.</jats:p><jats:p>This article is protected by copyright. All rights reserved</jats:p>

Topics

• nanoparticle
• nanocomposite
• impedance spectroscopy